# PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery

> **NCT03084536** · PHASE2 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 134 (actual)

## Conditions studied

- Breast Cancer
- Breast Cancer Female
- Cancer of Breast

## Interventions

- **DRUG:** Bupivacaine
- **DRUG:** Gabapentin
- **DRUG:** Celecoxib
- **DRUG:** Acetaminophen
- **DRUG:** Midazolam
- **DRUG:** Fentanyl

## Key facts

- **NCT ID:** NCT03084536
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-07
- **Primary completion:** 2021-02-25
- **Final completion:** 2021-02-25
- **Target enrollment:** 134 (ACTUAL)
- **Last updated:** 2024-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03084536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03084536, "PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03084536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*